Abstract
Neonatal lupus is categorized by typical clinical features and the presence of maternal auto-antibodies. Mothers are uncommonly affected with clinical disease. The major clinical manifestations in neonates are cardiac, dermatological and hepatic, with rare instances of haemolytic anaemia and thrombocytopenia. The major morbidity and mortality result from complete congenital heart block. Dermatological manifestations occur mainly over the face and present with plaques of erythema with central atrophy, a mid-facial erythema, atrophy around the eyes and a telangiectatic variety. The long term outcome is usually excellent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aylward RD. Congenital Heart Block. Br Med J. 1: 943. (1928)
McCuiston CH, Schoch ER Possible discoid lupus erythematosus in newborn infant: Report of a case with subsequent development of acute systemic lupus erythematosus in the mother. Arch Dermat. 28: 782–785 (1954).
Hogg Gr. Congenital acute lupus erythematosus associated with subendocardial fibroelastosis: report of a case. Am J Clin Path. 28: 648–654. (1957).
Franco HL, Weston WL, Tan EM, Peebles C, Forstot SL, Kohler PF. Association of antibodies to sicca syndrome antigen in newborns with lupus erythematosus and their mothers. Clin Res 28: 134A(1980). (Abstract).
Weston WL, Harmon C, Peebles C, et al. A serological marker for neonatal lupus erythematosus. Br J Dermatol 107(4): 377–382(1982).
Lee LA, Weston WL. Special considerations concerning the cutaneous manifestations of rheumatic diseases in children. In: Sontheimer RD, Provost TT. (Eds): Cutaneous Manifestations of Rheumatic Diseases. Baltimore: Williams and Wilkins. Pp 323–344. (1995).
Kitridou RC, Minta G. The neonatal lupus syndrome. In: Wallace DJ, Hahn BH (Eds).Dubois’ Lupus Erythematosus. 4th Edition. Philadelphia: Lea and Febiger. Pp. 516–522. (1993).
Ramsay-Goldman R, Horn D, Deng JS, et al. Anti SS-A antibodies and foetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 29: 1269–1273 (1986).
McCune AB, Weston WL, Lee LA. Maternal and foetal outcome in neonatal lupus erythematosus. Ann Int Med 106(4): 518–523(1987).
Thornton CM, Eichenfield LF, Shinall EA et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol. 33: 19–25 (1995).
Gochbereg SH: Congenital hear block. Am J Obstet Gynaecol. 88: 238–241 (1964).
Laxer RM, Roberts E, Gross KR et al. Liver disease in neonatal lupus erythematosus. J Pediatr. 116: 238–242(1990).
Lee LA, Reichlin M, Ruyle SZ, Weston WL. Neonatal lupus liver disease. Lupus. 2: 333–338 (1993).
Provost TT, Watson R, Gammon WR, Radowksy M, Harley JB, Reichlin M: The neonatal lupus syndrome associated with U1 RNP (nRNP) antibodies. New Eng J Med. 316(18): 1135–1138 (1987).
Silverman ED, Buyon J, Laxer RM, et al. Auto-antibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol. 100: 499–505 (1995).
Lee LA. Maternal autoantibodies and pregnancy: The neonatal lupus syndrome. Baillere’s Clin Rheumatol. 4(1): 69–84(1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krafchik, B.R. (1999). Neonatal Lupus Erythematosus. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4857-7_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7203-5
Online ISBN: 978-1-4615-4857-7
eBook Packages: Springer Book Archive